|
|
Volumn 16, Issue 3, 2000, Pages 317-321
|
|
Current and future antifungal therapy: New targets for antifungal therapy
|
|
Author keywords
Anti fungal compounds; Antifungal targets; Investigational azoles; Investigational polyenes
|
|
Indexed keywords
ALLYLAMINE;
AMPHOTERICIN B;
AMPHOTERICIN B LIPID COMPLEX;
ANIDULAFUNGIN;
ANTIFUNGAL AGENT;
BMS 181184;
CASPOFUNGIN;
CLOTRIMAZOLE;
ECHINOCANDIN;
FLUCYTOSINE;
GM 135402;
GM 191519;
GM 193663;
GM 211676;
GM 222712;
GM 237354;
IMIDAZOLE;
ITRACONAZOLE;
KETOCONAZOLE;
MICONAZOLE;
N DIMETHYLAMINOACETYLPARTRICIN;
NIKKOMYCIN;
NUCLEOSIDE ANALOG;
NYSTATIN;
PNEUMOCANDIN DERIVATIVE;
POLYENE ANTIBIOTIC AGENT;
PRADIMICIN DERIVATIVE;
SORDARIN DERIVATIVE;
THIOCARBAMIC ACID DERIVATIVE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANTIFUNGAL ACTIVITY;
ARTICLE;
ASPERGILLOSIS;
DRUG EFFICACY;
DRUG RESEARCH;
DRUG TARGETING;
FUSARIUM;
HUMAN;
IMMUNE DEFICIENCY;
LIVER TOXICITY;
MYCOSIS;
NEPHROTOXICITY;
PRIORITY JOURNAL;
ANTIFUNGAL AGENTS;
DRUG DESIGN;
FORECASTING;
HUMANS;
IMMUNOCOMPROMISED HOST;
MYCOSES;
NUCLEOSIDES;
POLYENES;
|
|
EID: 0033736593
PISSN: 09248579
EISSN: None
Source Type: Journal
DOI: 10.1016/S0924-8579(00)00258-2 Document Type: Article |
|
Times cited : (77)
|
|
References (9)
|
